Nasdaq Nordic: Nasdaq Stockholm Welcomes Scandion Oncology to the Nasdaq First North Growth Market
Stockholm, February 3, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in
Scandion Oncology A/S s shares (short name SCOL) commences today on Nasdaq
First North Growth Market. The company belongs to the Health care sector.
Scandion Oncology is the 4th company to be admitted to trading on Nasdaq s
Nordic markets in 2021.
Scandion Oncology was established to address one of the most important problems
in modern oncology: the treatment of cancers that have developed resistance to
chemotherapy. By doing this, Scandion Oncology is working to improve the
outcome and quality of life for cancer patients and that is the mission. The
Study reveals how ecDNA forms, drives cancer drug resistance ANI | Updated: Dec 24, 2020 11:54 IST
Washington [US], December 24 (ANI): Researchers led by Ludwig San Diego Member Don Cleveland and Peter Campbell of the Sanger Center have solved the mystery of how free-floating circular DNA fragments, which are almost exclusively found in cancer cells, drive gene amplification to generate drug resistance in cancer.
The research, published in the journal Nature, provides new insights into how cancers evolve to adapt to changing environments and suggests ways to reduce drug resistance by combining therapies. Drug resistance is the most problematic part of cancer therapy. If not for drug resistance, many cancer patients would survive, said Ofer Shoshani, a postdoctoral researcher in Cleveland s lab and the study s first author.
category 2 hurricane. we re going to have the latest track of the storm for you. and for the first time in history, a commercial spacecraft linking up with the international space station. let your geek flag fly, folks. we are going to take you live to outer space in just a moment. hi, everybody. welcome to early start. i m ashleigh banfield. look who s here! good morning. nice to have you here. i m alina cho. zoraida has the day off today. it is 5:00 a.m. in the east. on this friday before memorial, we ve got lots of news. we do, so let s get right to it. this is a big story. for the first time in 33 years in fact, the anniversary today new york police may finally have their man in the murder of etan patz 33 years ago. he is 51-year-old pedro hernandez. he is under arrest and is expected to be charged with second-degree murder. he was 19 at the time that 16-year-old the etan patz disappeared while walking on his bus stop in 1969. hernandez was working in a
susan candiotti is outside of the courthouse. susan, bring us up to date. reporter: fredricka, the latest information we have on the suspect in this case, pedro hernandez, is that he is not being held in jail at this time. instead, he is at bellevue hospital in new york, which is a very highly regarded public hospital, which has an equally highly regarded psychiatric unit as well. we are told that he is being evaluated. he is not under a suicide watch, according to police officials, at this time. so right now at the courthouse, we are waiting to find out when a hearing might be scheduled. this would be the first appearance for mr. hernandez at which time we expect that prosecutors will be announcing exactly what he will be charged with. now, it was flagged yesterday by police that they expected the charge to be second degree murder. but it will be the first opportunity we have to see him in court if in fact this appearance does come today as expected. fredricka? susan, ye